Aemetis (AMTX) Studies Q1 Loss, Lags Income Estimates

Date:

Aemetis (AMTX) got here out with a quarterly lack of $0.58 per share versus the Zacks Consensus Estimate of a lack of $0.43. This compares to lack of $0.73 per share a 12 months in the past. These figures are adjusted for non-recurring objects.

This quarterly report represents an earnings shock of -34.88%. 1 / 4 in the past, it was anticipated that this renewable fuels and specialty chemical substances firm would submit a lack of $0.35 per share when it really produced a lack of $0.64, delivering a shock of -82.86%.

During the last 4 quarters, the corporate has not been capable of surpass consensus EPS estimates.

Aemetis, which belongs to the Zacks Biofuels business, posted revenues of $72.63 million for the quarter ended March 2024, lacking the Zacks Consensus Estimate by 7.76%. This compares to year-ago revenues of $2.15 million. The corporate has not been capable of beat consensus income estimates over the past 4 quarters.

The sustainability of the inventory’s speedy worth motion based mostly on the recently-released numbers and future earnings expectations will largely rely upon administration’s commentary on the earnings name.

Aemetis shares have misplaced about 21% because the starting of the 12 months versus the S&P 500’s achieve of 8.8%.

What’s Subsequent for Aemetis?

Whereas Aemetis has underperformed the market to date this 12 months, the query that involves traders’ minds is: what’s subsequent for the inventory?

There are not any simple solutions to this key query, however one dependable measure that may assist traders handle that is the corporate’s earnings outlook. Not solely does this embody present consensus earnings expectations for the approaching quarter(s), but in addition how these expectations have modified these days.

Empirical analysis exhibits a robust correlation between near-term inventory actions and developments in earnings estimate revisions. Buyers can monitor such revisions by themselves or depend on a tried-and-tested ranking instrument just like the Zacks Rank, which has a formidable monitor file of harnessing the ability of earnings estimate revisions.

Forward of this earnings release, the estimate revisions pattern for Aemetis: combined. Whereas the magnitude and path of estimate revisions might change following the corporate’s just-released earnings report, the present standing interprets right into a Zacks Rank #3 (Maintain) for the inventory. So, the shares are anticipated to carry out consistent with the market within the close to future. You’ll be able to see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Will probably be fascinating to see how estimates for the approaching quarters and present fiscal 12 months change within the days forward. The present consensus EPS estimate is -$0.41 on $89.23 million in revenues for the approaching quarter and -$1.52 on $379.58 million in revenues for the present fiscal 12 months.

Buyers must be conscious of the truth that the outlook for the business can have a fabric affect on the efficiency of the inventory as properly. By way of the Zacks Business Rank, Biofuels is presently within the backside 23% of the 250 plus Zacks industries. Our analysis exhibits that the highest 50% of the Zacks-ranked industries outperform the underside 50% by an element of greater than 2 to 1.

One other inventory from the identical business, REX (REX), has but to report outcomes for the quarter ended April 2024.

This ethanol producer is predicted to submit quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of +3.3%. The consensus EPS estimate for the quarter has been revised 32.4% decrease over the past 30 days to the present stage.

REX’s revenues are anticipated to be $140 million, down 34.2% from the year-ago quarter.

Zacks Names “Single Greatest Decide to Double”

From hundreds of shares, 5 Zacks consultants every have chosen their favourite to skyrocket +100% or extra in months to come back. From these 5, Director of Analysis Sheraz Mian hand-picks one to have probably the most explosive upside of all.

It’s an American AI firm that’s driving low proper now, nevertheless it has rounded up purchasers like BMW, GE, Dell Laptop, and Bosch. It has prospects for not simply doubling however quadrupling within the 12 months to come back. In fact, all our picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Boston Beer Firm which shot up +143.0% in little greater than 9 months and NVIDIA which boomed +175.9% in a single 12 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Aemetis, Inc (AMTX) : Free Stock Analysis Report

REX American Resources Corporation (REX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.

Share post:

Subscribe

Popular

More like this
Related